These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 29438395)

  • 1. Recognition of sites of functional specialisation in all known eukaryotic protein kinase families.
    Kalaivani R; Reema R; Srinivasan N
    PLoS Comput Biol; 2018 Feb; 14(2):e1005975. PubMed ID: 29438395
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of changing the site of activating phosphorylation in CDK2 from threonine to serine.
    Kaldis P; Cheng A; Solomon MJ
    J Biol Chem; 2000 Oct; 275(42):32578-84. PubMed ID: 10931829
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of conservation within and between the Ser/Thr and Tyr protein kinase family: proposed model for the catalytic domain of the epidermal growth factor receptor.
    Singh J
    Protein Eng; 1994 Jul; 7(7):849-58. PubMed ID: 7971947
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of Thr160 phosphorylation of Cdk2 in substrate recognition.
    Holmes JK; Solomon MJ
    Eur J Biochem; 2001 Sep; 268(17):4647-52. PubMed ID: 11532001
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Crystal structure of cyclin-dependent kinase 2.
    De Bondt HL; Rosenblatt J; Jancarik J; Jones HD; Morgan DO; Kim SH
    Nature; 1993 Jun; 363(6430):595-602. PubMed ID: 8510751
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New structural insights into phosphorylation-free mechanism for full cyclin-dependent kinase (CDK)-cyclin activity and substrate recognition.
    Zheng F; Quiocho FA
    J Biol Chem; 2013 Oct; 288(42):30682-30692. PubMed ID: 24022486
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The complete pathway for catalytic activation of the mitogen-activated protein kinase, ERK2.
    Prowse CN; Deal MS; Lew J
    J Biol Chem; 2001 Nov; 276(44):40817-23. PubMed ID: 11524422
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural basis for substrate recognition and control in protein kinases.
    Johnson LN
    Ernst Schering Res Found Workshop; 2001; (34):47-69. PubMed ID: 11394047
    [No Abstract]   [Full Text] [Related]  

  • 9. A novel member of the cyclin-dependent kinase family in Paramecium tetraurelia.
    Zhang H; Berger JD
    J Eukaryot Microbiol; 1999; 46(5):482-91. PubMed ID: 10519216
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of an oriented peptide library to determine the optimal substrates of protein kinases.
    Songyang Z; Blechner S; Hoagland N; Hoekstra MF; Piwnica-Worms H; Cantley LC
    Curr Biol; 1994 Nov; 4(11):973-82. PubMed ID: 7874496
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alternative binding modes of an inhibitor to two different kinases.
    De Moliner E; Brown NR; Johnson LN
    Eur J Biochem; 2003 Aug; 270(15):3174-81. PubMed ID: 12869192
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of the structure-activity relationship of four herpesviral UL97 subfamily protein kinases reveals partial but not full functional conservation.
    Romaker D; Schregel V; Maurer K; Auerochs S; Marzi A; Sticht H; Marschall M
    J Med Chem; 2006 Nov; 49(24):7044-53. PubMed ID: 17125257
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synergistic activation of SAPK1/JNK1 by two MAP kinase kinases in vitro.
    Lawler S; Fleming Y; Goedert M; Cohen P
    Curr Biol; 1998 Dec 17-31; 8(25):1387-90. PubMed ID: 9889102
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reciprocal activation by cyclin-dependent kinases 2 and 7 is directed by substrate specificity determinants outside the T loop.
    Garrett S; Barton WA; Knights R; Jin P; Morgan DO; Fisher RP
    Mol Cell Biol; 2001 Jan; 21(1):88-99. PubMed ID: 11113184
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mass spectrometry and site-directed mutagenesis identify several autophosphorylated residues required for the activity of PrkC, a Ser/Thr kinase from Bacillus subtilis.
    Madec E; Stensballe A; Kjellström S; Cladière L; Obuchowski M; Jensen ON; Séror SJ
    J Mol Biol; 2003 Jul; 330(3):459-72. PubMed ID: 12842463
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Both p16 and p21 families of cyclin-dependent kinase (CDK) inhibitors block the phosphorylation of cyclin-dependent kinases by the CDK-activating kinase.
    Aprelikova O; Xiong Y; Liu ET
    J Biol Chem; 1995 Aug; 270(31):18195-7. PubMed ID: 7629134
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of phosphorylation of threonine 160 on cyclin-dependent kinase 2 structure and activity.
    Brown NR; Noble ME; Lawrie AM; Morris MC; Tunnah P; Divita G; Johnson LN; Endicott JA
    J Biol Chem; 1999 Mar; 274(13):8746-56. PubMed ID: 10085115
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Signalling specificity of Ser/Thr protein kinases through docking-site-mediated interactions.
    Biondi RM; Nebreda AR
    Biochem J; 2003 May; 372(Pt 1):1-13. PubMed ID: 12600273
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evolution of protein kinase substrate recognition at the active site.
    Bradley D; Beltrao P
    PLoS Biol; 2019 Jun; 17(6):e3000341. PubMed ID: 31233486
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stimulation of the Raf/MEK/ERK cascade is necessary and sufficient for activation and Thr-160 phosphorylation of a nuclear-targeted CDK2.
    Lents NH; Keenan SM; Bellone C; Baldassare JJ
    J Biol Chem; 2002 Dec; 277(49):47469-75. PubMed ID: 12359725
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.